CN112913947A - Gynostemma pentaphylla lipid-lowering tea - Google Patents
Gynostemma pentaphylla lipid-lowering tea Download PDFInfo
- Publication number
- CN112913947A CN112913947A CN202110403645.XA CN202110403645A CN112913947A CN 112913947 A CN112913947 A CN 112913947A CN 202110403645 A CN202110403645 A CN 202110403645A CN 112913947 A CN112913947 A CN 112913947A
- Authority
- CN
- China
- Prior art keywords
- parts
- gynostemma pentaphylla
- tea
- lipid
- lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
The invention discloses a gynostemma pentaphylla lipid-lowering tea, which is prepared from the following components in parts by weight: 4-6 parts of raw hawthorn, 3-6 parts of gynostemma pentaphylla, 2-4 parts of cassia occidentalis, 0.5-1.5 parts of uncaria, 0.5-1.5 parts of lotus leaf, 0.5-1.5 parts of dried orange peel and 0.5-1.5 parts of tea. The gynostemma pentaphylla has the effects of remarkably reducing cholesterol, triglyceride and low-density lipoprotein, increasing high-density lipoprotein, protecting cells of the inner wall of a blood vessel, preventing lipid from depositing on the blood vessel wall and resisting arteriosclerosis, and is taken by patients suffering from hyperlipidemia at different degrees according to the mixture ratio of raw hawthorn, gynostemma pentaphylla, cassia occidentalis, uncaria, lotus leaves, dried orange peel and tea in the range of components, so that the gynostemma pentaphylla has the characteristics of quick response and good treatment effect.
Description
Technical Field
The invention relates to the technical field of health-care tea, and particularly relates to gynostemma pentaphylla lipid-lowering tea.
Background
In recent years, the blood lipid level and the change trend of people in China are concerned by scholars at home and abroad. Statistically, the prevalence of hyperlipidemia increases year by year, with serum total cholesterol or triglycerides rising in about 10% to 20% of adults and blood lipids rising in about 10% of children. The method has close relation with the reasons that the living standard of people in China is continuously improved, the dietary structure and the habits are changed, and the like. In addition, hypertension, cerebral hemorrhage, cerebral embolism, liver cirrhosis, fatty liver, renal failure, diabetes and other diseases can be caused by long-term hyperlipemia.
Currently, treatment of hyperlipidemia is mainly focused on improving various abnormal blood lipid components, particularly on raising high density lipoprotein cholesterol and lowering low density lipoprotein cholesterol. Due to the single components and definite curative effect, western medicines have been widely used for treating hyperlipidemia. According to their structure, mechanism of action and range of action, the commonly used blood lipid-lowering drugs in the world can be roughly divided into the following categories: (1) phenoxy aromatic acids mainly reducing triglyceride, wherein gemfibrozil, fenofibrate and other drugs are taken as representatives; (2) nicotinic acid mainly used for reducing triglyceride in blood serum and medicines such as oxygen methylpyrazine, acipimox and the like are taken as representatives; (3) HMG-CoA reductase inhibitors mainly having the effect of reducing cholesterol, wherein simvastatin (used in a positive group of the experiment) and lovastatin are taken as representatives; (4) the derivative of coenzyme A can be increased while reducing serum total cholesterol and triglyceride, and is represented by pantethine and other related medicines; (5) in addition, related lipid-lowering drugs such as clofibrate and polyenoic fatty acids are also available. The lipid-lowering medicines used for treating hyperlipidemia belong to western medicines, and have good effects and a large number of adverse reactions (such as nausea, liver function damage, rhabdomyolysis and the like).
Therefore, due to the adverse reactions generated by the western medicines for reducing the lipid, the health care product which is fast in metabolism and good in treatment effect in a human body and can be directly introduced needs to be developed.
Disclosure of Invention
Aiming at the technical problems, the invention provides the gynostemma pentaphylla lipid-lowering tea which is prepared by preparing bagged health-care tea with formula components and is provided for patients to drink to lower the blood lipid of the patients.
In order to achieve the purpose, the invention is realized by the following technical scheme:
the gynostemma pentaphylla lipid-lowering tea comprises the following components in parts by weight: 4-6 parts of raw hawthorn, 3-6 parts of gynostemma pentaphylla, 2-4 parts of cassia occidentalis, 0.5-1.5 parts of uncaria, 0.5-1.5 parts of lotus leaf, 0.5-1.5 parts of dried orange peel and 0.5-1.5 parts of tea.
Compared with the prior art, the invention has the following advantages: the gynostemma pentaphylla has the effects of remarkably reducing cholesterol, triglyceride and low-density lipoprotein, increasing high-density lipoprotein, protecting cells of the inner wall of a blood vessel, preventing lipid from depositing on the blood vessel wall and resisting arteriosclerosis, and is taken by patients suffering from hyperlipidemia at different degrees according to the mixture ratio of raw hawthorn, gynostemma pentaphylla, cassia occidentalis, uncaria, lotus leaves, dried orange peel and tea in the range of components, so that the gynostemma pentaphylla has the characteristics of quick response and good treatment effect.
More preferably: the gynostemma pentaphylla lipid-lowering tea comprises the following components in parts by weight: 5 parts of raw hawthorn, 4 parts of gynostemma pentaphylla, 3 parts of cassia occidentalis, 1 part of uncaria, 1 part of lotus leaf, 1 part of dried orange peel and 1 part of tea.
By adopting the technical scheme, the lipid-lowering tea with the formula has the medicinal effects of clearing away heart-fire, relieving restlessness, detoxifying, sobering up, promoting the production of body fluid, quenching thirst, reducing pathogenic fire, improving eyesight, stopping dysentery, removing dampness and the like, and can consolidate the curative effect after being taken by gynostemma pentaphylla lipid-lowering tea for patients with refractory hyperlipidemia.
The method is further optimized as follows: the formula of the gynostemma pentaphylla lipid-lowering tea comprises the following components: 4 parts of raw hawthorn, 3 parts of gynostemma pentaphylla, 2 parts of cassia occidentalis, 0.5 part of uncaria, 0.5 part of lotus leaf, 0.5 part of dried orange peel and 0.5 part of tea.
By adopting the technical scheme, the traditional Chinese medicine composition is used for treating patients with mild hyperlipidemia.
The method is further optimized as follows: the formula of the gynostemma pentaphylla lipid-lowering tea comprises the following components: 6 parts of raw hawthorn, 6 parts of gynostemma pentaphylla, 4 parts of cassia occidentalis, 1.5 parts of uncaria, 1.5 parts of lotus leaves, 1.5 parts of dried orange peel and 1.5 parts of tea.
By adopting the technical scheme, the traditional Chinese medicine composition is used for treating patients with severe hyperlipidemia.
The method is further optimized as follows: weighing the gynostemma pentaphylla lipid-lowering tea according to parts by weight, and packaging into bags.
By adopting the technical scheme, the traditional Chinese medicine composition is used for treating hyperlipidemia with different degrees of severity of different patients according to different parts by weight.
More preferably: the tea is selenium-rich tea.
By adopting the technical scheme, the selenium-rich tea has high selenium content, and selenium and vitamin E, allicin, linoleic acid, germanium, zinc and other nutrients have a synergistic antioxidant effect and increase antioxidant activity. Meanwhile, selenium has the effects of reducing and relieving heavy metal toxicity, and the selenium-rich tea has the effects of softening blood vessels and increasing blood flow rate, so that the aim of finally reducing blood fat is fulfilled.
Detailed Description
The gynostemma pentaphylla lipid-lowering tea comprises the following components in parts by weight: 4-6 parts of raw hawthorn, 3-6 parts of gynostemma pentaphylla, 2-4 parts of cassia occidentalis, 0.5-1.5 parts of uncaria, 0.5-1.5 parts of lotus leaf, 0.5-1.5 parts of dried orange peel and 0.5-1.5 parts of tea. The gynostemma pentaphylla has the functions of obviously reducing cholesterol, triglyceride and low-density lipoprotein, increasing high-density lipoprotein, protecting cells on the inner wall of a blood vessel, preventing lipid from depositing on the blood vessel wall and resisting arteriosclerosis, the raw hawthorn, the gynostemma pentaphylla, the cassia occidentalis, the uncaria, the lotus leaf, the dried orange peel and the tea are proportioned according to the component range and are used by patients with hyperlipidemia with different degrees, the tea has the characteristics of quick response and good treatment effect, and according to the statistics of clinical experimental data, 116 patients in the treatment have hyperlipidemia, the patients are respectively drunk with the lipid-lowering tea, and other lipid-lowering and auxiliary medicines are stopped taking, patients with different degrees have obvious lipid-lowering effect between 1 week and 3 weeks, and after 1 month, the blood lipid of 104 patients is reduced to the normal index range, so that the curative effect is achieved, the cure rate is over 89.6 percent, and the clinical effect is obvious.
Specifically, the gynostemma pentaphylla lipid-lowering tea of the embodiment comprises the following components in parts by weight: 5 parts of raw hawthorn, 4 parts of gynostemma pentaphylla, 3 parts of cassia occidentalis, 1 part of uncaria, 1 part of lotus leaf, 1 part of dried orange peel and 1 part of tea. The blood lipid reducing tea has the effects of clearing heart fire, relieving restlessness, removing toxic substance, relieving hangover, promoting fluid production, quenching thirst, lowering pathogenic fire, improving eyesight, relieving dysentery, and eliminating dampness, and can be administered to patients with intractable hyperlipidemia to consolidate the curative effect.
Specifically, the formula of the gynostemma pentaphylla lipid-lowering tea in the embodiment is as follows: 4 parts of raw hawthorn, 3 parts of gynostemma pentaphylla, 2 parts of cassia occidentalis, 0.5 part of uncaria, 0.5 part of lotus leaf, 0.5 part of dried orange peel and 0.5 part of tea, and is used for treating patients with mild hyperlipidemia.
Specifically, the formula of the gynostemma pentaphylla lipid-lowering tea in the embodiment is as follows: 6 parts of raw hawthorn, 6 parts of gynostemma pentaphylla, 4 parts of cassia occidentalis, 1.5 parts of uncaria, 1.5 parts of lotus leaves, 1.5 parts of dried orange peel and 1.5 parts of tea, and is used for treating patients with severe hyperlipidemia.
Specifically, the gynostemma pentaphylla lipid-lowering tea is weighed according to parts by weight and then packaged into a bag, and is used for treating hyperlipidemia of different patients with different degrees of severity according to different parts by weight.
Specifically, the tea leaves in the embodiment are selenium-rich tea, the selenium content in the selenium-rich tea is high, and the selenium and the nutrients such as vitamin E, allicin, linoleic acid, germanium, zinc and the like have the synergistic antioxidant effect and increase the antioxidant activity. Meanwhile, selenium has the effects of reducing and relieving heavy metal toxicity, and the selenium-rich tea has the effects of softening blood vessels and increasing blood flow rate, so that the aim of finally reducing blood fat is fulfilled.
Wherein, the effects and functions of the hawthorn are as follows: sweet and sour, slightly warm, entering spleen, stomach and liver channels, has the efficacies of promoting digestion, invigorating stomach, promoting qi circulation, removing blood stasis, eliminating turbid pathogen and reducing blood fat, and is used for treating meat food stagnation, gastric and abdominal distension, or diarrhea, dysentery, abdominal pain, blood stasis, amenorrhea, postpartum blood stasis, heart and abdominal stabbing pain, chest stuffiness and pains, hernia pain and hyperlipidemia.
Efficacy and action of Cassia occidentalis: salty and bitter taste and cool nature; it enters liver, gallbladder and kidney meridians, and has the effects of dispelling pathogenic wind, clearing away heat, removing toxic substance, promoting diuresis, and treating wind-heat type common cold, influenza, acute conjunctivitis, jaundice due to damp-heat pathogen, acute and chronic nephritis, leukorrhagia, lymphoid tuberculosis, skin ulcer, carbuncle, furuncle, and mastitis.
The effects and actions of uncaria are as follows: the nature and taste of the herbs are sweet in channel and slightly cold. It enters liver and pericardium meridians. The efficacy of the traditional Chinese medicine uncaria is to extinguish wind and stop spasm, clear liver heat and calm liver yang.
The lotus leaf has the following effects: bitter, pungent, slightly astringent and cool in nature, and enter heart, liver and spleen meridians; fragrant ascending and dispersing; has effects of removing summer-heat, promoting diuresis, invigorating spleen, invigorating yang, removing blood stasis, and stopping bleeding.
The efficacy and the effect of the dried orange peel are as follows: pungent and bitter in flavor and warm in nature, enter spleen, stomach and lung meridians, disperse and disperse in flavor and can ascend and descend; wild chrysanthemum flower: the tea has slight cold property, bitter and pungent taste, enters lung and liver channels, has little toxicity, is not suitable for eating, and has the effects of clearing heat and removing toxicity; dispelling wind and calming the liver.
The selenium-rich tea has the following effects: the gynostemma pentaphylla lipid-lowering tea has the medicinal effects of refreshing and clearing away heart-fire, clearing away summer-heat, helping digestion and reducing phlegm, removing greasiness and losing weight, clearing away heart-fire and relieving restlessness, detoxifying and sobering up, promoting the production of body fluid to quench thirst, reducing pathogenic fire and improving eyesight, stopping dysentery and removing dampness and the like, and can consolidate the curative effect after being taken by a patient suffering from refractory hyperlipidemia.
The treatment results of 4 clinical trials are described below:
patient one woman, age 44, symptoms: dizziness is 6 days, and the diagnosis result is as follows: the test results of the hyperlipidemia and the blood fat items are respectively as follows: the total cholesterol is 6.97mmol/L, which is higher; the triglyceride is 11.94mmol/L, which is obviously increased; the high-density lipoprotein cholesterol is 2.07mmol/L, the low-density lipoprotein cholesterol is 4.3mmol/L, and after taking the gynostemma pentaphylla lipid-lowering tea for 1 week, the blood lipid reexamination results are respectively as follows: the total cholesterol is 3.97mmol/L, and is obviously reduced to a normal range; triglyceride is 7.94mmol/L, high density lipoprotein cholesterol is 2.01mmol/L, low density lipoprotein cholesterol is 4.3mmol/L, and after taking gynostemma pentaphylla tea for 1 week, the blood fat reexamination results are respectively as follows: the total cholesterol is 3.81mmol/L, and is obviously reduced to a normal range; triglyceride is 1.71mmol/L, high density lipoprotein cholesterol is 2.01mmol/L, low density lipoprotein cholesterol is 3.91mmol/L, and after 2 weeks of treatment, the blood lipid index reaches normal, thus achieving the treatment effect.
Patient two women, 51 years old, symptoms: dizziness and headache for 4 days, and the diagnosis result is as follows: the test results of the hyperlipidemia and the blood fat items are respectively as follows: the total cholesterol is 7.1mmol/L, which is higher; the triglyceride is 9.49mmol/L, which is obviously increased; the high density lipoprotein cholesterol is 2.11mmol/L, which is higher; the low-density lipoprotein cholesterol is 3.97mmol/L, and after taking the gynostemma pentaphylla lipid-lowering tea for 1 week, the blood lipid reexamination results are respectively as follows: the total cholesterol is 6.87mmol/L, and is obviously reduced to a normal range; triglyceride is 5.78mmol/L, high density lipoprotein cholesterol is 1.99mmol/L, low density lipoprotein cholesterol is 4.1mmol/L, and after taking herba Gynostemmatis tea for 1 week, the blood lipid review results are respectively: the total cholesterol is 6.39mmol/L, and is obviously reduced to a normal range; triglyceride is 2.04mmol/L, high density lipoprotein cholesterol is 2.03mmol/L, low density lipoprotein cholesterol is 3.89mmol/L, and after 2 weeks of treatment, the blood lipid index reaches normal, thereby achieving the treatment effect.
Patient three men, 38 years old, symptoms: dizziness is 6 days, and the diagnosis result is as follows: the test results of the hyperlipidemia and the blood fat items are respectively as follows: the total cholesterol is 6.66mmol/L, which is higher; triglyceride is 7.68mmol/L, and is obviously increased; 1.94mmol/L of high density lipoprotein cholesterol and 3.6mmol/L of low density lipoprotein cholesterol, and after taking the gynostemma pentaphylla lipid-lowering tea for 1 week, the blood lipid reexamination results are respectively as follows: the total cholesterol is 5.89mmol/L, and is obviously reduced to a normal range; triglyceride is 6.45mmol/L, high density lipoprotein cholesterol is 1.92mmol/L, low density lipoprotein cholesterol is 3.6mmol/L, and after taking gynostemma pentaphylla tea for 1 week, the blood fat reexamination results are respectively as follows: the total cholesterol is 6.51mmol/L, and is obviously reduced to a normal range; 1.75mmol/L of triglyceride, 1.90mmol/L of high density lipoprotein cholesterol and 3.6mmol/L of low density lipoprotein cholesterol, and after 2 weeks of treatment, the blood lipid index reaches normal, thus achieving the treatment effect.
Patient four men, 45 years old, symptoms: dizziness for 3 days, and the diagnosis result is as follows: the test results of the hyperlipidemia and the blood fat items are respectively as follows: the total cholesterol is 7.35mmol/L, which is higher; triglyceride is 7.67mmol/L, and is obviously increased; 1.95mmol/L of high-density lipoprotein cholesterol and 4.3mmol/L of low-density lipoprotein cholesterol, and after taking the gynostemma pentaphylla lipid-lowering tea for 1 week, the blood lipid reexamination results are respectively as follows: the total cholesterol is 3.97mmol/L, and is obviously reduced to a normal range; triglyceride is 7.94mmol/L, high density lipoprotein cholesterol is 1.93mmol/L, low density lipoprotein cholesterol is 4.3mmol/L, and after taking herba Gynostemmatis tea for 1 week, the blood lipid review results are respectively: the total cholesterol is 3.81mmol/L, and is obviously reduced to a normal range; triglyceride is 1.71mmol/L, high density lipoprotein cholesterol is 1.89mmol/L, low density lipoprotein cholesterol is 3.91mmol/L, and after 2 weeks of treatment, the blood lipid index reaches normal, thus achieving the treatment effect.
From the analysis of the experimental data and the medical treatment effect nucleation of each component, the gynostemma pentaphylla lipid-lowering tea has the main treatment effect of reducing total cholesterol and triglyceride in blood fat in a short time, and has the characteristics of safety and health with less side effect by reducing blood fat indexes in the form of drinking health-care tea.
The present embodiment is only for explaining the invention, and it is not limited to the invention, and those skilled in the art can make modifications to the embodiment as necessary without inventive contribution after reading the present specification, but all of them are protected by the patent law within the scope of the present invention.
Claims (6)
1. A gynostemma pentaphylla lipid-lowering tea is characterized in that: the formula of the gynostemma pentaphylla lipid-lowering tea comprises the following components in parts by weight: 4-6 parts of raw hawthorn, 3-6 parts of gynostemma pentaphylla, 2-4 parts of cassia occidentalis, 0.5-1.5 parts of uncaria, 0.5-1.5 parts of lotus leaf, 0.5-1.5 parts of dried orange peel and 0.5-1.5 parts of tea.
2. The gynostemma pentaphylla lipid-lowering tea according to claim 1, wherein: the formula of the gynostemma pentaphylla lipid-lowering tea is respectively as follows: 5 parts of raw hawthorn, 4 parts of gynostemma pentaphylla, 3 parts of cassia occidentalis, 1 part of uncaria, 1 part of lotus leaf, 1 part of dried orange peel and 1 part of tea.
3. The gynostemma pentaphylla lipid-lowering tea according to claim 1, wherein: the formula of the gynostemma pentaphylla lipid-lowering tea is respectively as follows: 4 parts of raw hawthorn, 3 parts of gynostemma pentaphylla, 2 parts of cassia occidentalis, 0.5 part of uncaria, 0.5 part of lotus leaf, 0.5 part of dried orange peel and 0.5 part of tea.
4. The gynostemma pentaphylla lipid-lowering tea according to claim 1, wherein: the formula of the gynostemma pentaphylla lipid-lowering tea is respectively as follows: 6 parts of raw hawthorn, 6 parts of gynostemma pentaphylla, 4 parts of cassia occidentalis, 1.5 parts of uncaria, 1.5 parts of lotus leaf, 1.5 parts of dried orange peel and 1.5 parts of tea.
5. The gynostemma pentaphylla lipid-lowering tea according to claim 1, wherein: the gynostemma pentaphylla lipid-lowering tea is packaged into bags after being weighed according to parts by weight.
6. The gynostemma pentaphylla lipid-lowering tea according to claim 1, wherein: the tea is selenium-rich tea.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110403645.XA CN112913947A (en) | 2021-04-15 | 2021-04-15 | Gynostemma pentaphylla lipid-lowering tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110403645.XA CN112913947A (en) | 2021-04-15 | 2021-04-15 | Gynostemma pentaphylla lipid-lowering tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112913947A true CN112913947A (en) | 2021-06-08 |
Family
ID=76174448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110403645.XA Pending CN112913947A (en) | 2021-04-15 | 2021-04-15 | Gynostemma pentaphylla lipid-lowering tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112913947A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101612255A (en) * | 2009-07-21 | 2009-12-30 | 北京勃然制药有限公司 | Prescription of a kind of fat eliminating tea and preparation method thereof |
| CN103416746A (en) * | 2013-07-16 | 2013-12-04 | 湖北恩施聚硒康农业科技有限公司 | Lipid-lowing selenium-rich tea pigment and production method thereof |
| CN106729388A (en) * | 2016-12-16 | 2017-05-31 | 汪杰峰 | It is a kind of to treat Chinese medicine preparation of hyperlipidemia and preparation method thereof |
| CN108271893A (en) * | 2018-04-13 | 2018-07-13 | 黄继斌 | Blood fat reducing tea |
-
2021
- 2021-04-15 CN CN202110403645.XA patent/CN112913947A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101612255A (en) * | 2009-07-21 | 2009-12-30 | 北京勃然制药有限公司 | Prescription of a kind of fat eliminating tea and preparation method thereof |
| CN103416746A (en) * | 2013-07-16 | 2013-12-04 | 湖北恩施聚硒康农业科技有限公司 | Lipid-lowing selenium-rich tea pigment and production method thereof |
| CN106729388A (en) * | 2016-12-16 | 2017-05-31 | 汪杰峰 | It is a kind of to treat Chinese medicine preparation of hyperlipidemia and preparation method thereof |
| CN108271893A (en) * | 2018-04-13 | 2018-07-13 | 黄继斌 | Blood fat reducing tea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101011561B (en) | Modern traditional Chinese medicine oral preparation huanglianwendan decoction and production method thereof | |
| KR100842634B1 (en) | Physiologically functional drinks and compositions | |
| JP5512590B2 (en) | A composition for relieving and preventing hangover and a drink for relieving hangover before and after drinking | |
| CN101773595B (en) | Herbal tea for clearing liver and improving eyesight | |
| CN104904913A (en) | Healthy tea having hypertension, hyperglycemia and hyperlipidemia reducing functions | |
| CN108835638A (en) | A kind of Soboring-up liver-protecting improves the food and preparation method thereof of immunity | |
| CN113456725A (en) | Product for relieving alcoholism and preparation method thereof | |
| CN106387900A (en) | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof | |
| CN112913947A (en) | Gynostemma pentaphylla lipid-lowering tea | |
| US20030096020A1 (en) | Novel herbal composition for the management of bronchial asthma and a process of manufacturing the same | |
| CN113244367A (en) | Medicated diet for people with hyperlipidemia | |
| CN106800992A (en) | Mulberry fruit donkey-hide gelatin ginseng liquor and preparation method thereof | |
| CN111407869A (en) | Medicinal and edible traditional Chinese medicine composition for improving female weak constitution and preparation method thereof | |
| CN111686222A (en) | Chinese herbal medicine for dispelling effects of alcohol and preparation method thereof | |
| CN114404484A (en) | Traditional Chinese medicine composition with effect of reducing hyperlipidemia | |
| CN106902246A (en) | A kind of tea bag with health-care efficacies such as function of spleen and stomach regulating, maintenance blood vessel, three high drops | |
| CN115462430A (en) | Sore-throat relieving and swelling eliminating tea and preparation method thereof | |
| Thirumalaiselvi et al. | Antidiabetic effect of iron-rich fortified amla (Emblica officinalis) Ready to Serve (RTS) health drink | |
| CN111450202A (en) | A Chinese medicinal composition for preventing and treating hypertension, hyperglycemia and hyperlipidemia, and its preparation method | |
| CN104381450A (en) | Health milk for treatment of gastric mucosal injury and preparation method thereof | |
| CN104509787A (en) | Healthful porridge for prevention of gestational diabetes mellitus and preparation method thereof | |
| CN111617205A (en) | Compound traditional Chinese medicine for treating phlegm-heat internal disturbance type neurasthenia | |
| CN111869875A (en) | A food composition with blood lipid regulating effect | |
| CN103751537A (en) | Preparation method of traditional Chinese medicine for treating hyperlipemia caused by overeating deep-fried food | |
| CN116270910A (en) | Summer heat clearing and fluid supplementing electrolyte anti-fatigue composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |